Scarica l'app Stockscreener
0.5429
3.05%
-0.0171
Dopo l'orario di chiusura:
.56
0.0171
+3.15%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché MBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.56
Aprire:
$0.553299
Volume 24 ore:
37,376
Relative Volume:
0.36
Capitalizzazione di mercato:
$4.11M
Reddito:
-
Utile/perdita netta:
$-2.72M
Rapporto P/E:
-1.1308
EPS:
-0.4801
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
+0.99%
1M Prestazione:
-8.60%
6M Prestazione:
-43.36%
1 anno Prestazione:
-63.07%
Intervallo 1D:
$0.5322
$0.5582
Intervallo di 1 settimana:
$0.5322
$0.5609
Portata 52W:
$0.525
$1.85
Mustang Bio Inc Stock (MBIO) Company Profile
Nome
Mustang Bio Inc
Settore
Industria
Telefono
(781) 652-4500
Indirizzo
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.5429 | 4.34M | 0 | -2.72M | -4.88M | -0.4801 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-10-02 | Iniziato | B. Riley FBR | Buy |
| 2019-11-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mustang Bio Inc Borsa (MBIO) Ultime notizie
Mustang (MBIO) EPS and Revenue: EPS Misses Its Estimate in the Latest Session; Market Response: The Market Price Moves 0.70% Higher in the Latest ReadingManagement Tone Analysis - vinanet.vn
Pediatrix (MD) Trading-Day Recap: Ends Higher by 0.84% at $26.56 on the Day; Level Position: Support at $25.23 and Resistance at $27.89 Frame the RangeReversal Trade - Vinanet
Mustang Bio Stock Price Forecast. Should You Buy MBIO? - StockInvest.us
BHE Q2 2026 Earnings: EPS Beats Estimates by 8.4% as Bottom-Line Strength Drives Shares HigherROIC Trend Report - Vinanet
Mustang Bio (MBIO) Edges Higher by 3% as Shares Test Key Resistance at $0.64Dark Pool Prints - Vinanet
Mustang Bio Inc. (MBIO) Holds Steady at $0.60 as Narrow Trading Range PersistsFund Manager Survey - vinanet.vn
Mustang Bio Inc (MBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Segment Evaluation and Major Growth Areas in the Viral Vector Production (Research-Use) Market - openPR.com
Leading Companies Consolidating Their Presence in the Viral Vector Manufacturing Market - openPR.com
Mustang Bio Q2 net loss widens 41% to $1.07 million - Bitget
MUSTANG BIO, INC. Q2 2026: Net income $(1.07)M, EPS $(0.16) — 10-Q Summary - TradingView
MBIO: Net loss widened, cash reserves declined, and Nasdaq delisting risk remains amid ongoing R&D focus - TradingView
Mustang Bio, Inc. (NASDAQ: MBIO) posts $2.0M loss and faces Nasdaq bid-price warning - Stock Titan
Mustang Bio (MBIO) Holds $0.58 Support Zone as Gene Therapy Stock Ticks HigherBreakout Confirmation - dars.gov.et
Glioblastoma Pipeline 2026: FDA Approvals, Therapies, - openPR.com
Mustang Bio Inc (MBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mustang Bio, Inc. Revenue Breakdown – NASDAQ:MBIO - TradingView
Mustang Bio Inc (MBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mustang Bio Inc (MBIO) Cash Flow - TradingKey
MBIO|Mustang Bio Inc|Price:0.560|Chg%:-0.002 - TradingKey
TradingKey - TradingKey
MBIO Q4 2024 Earnings: Deep EPS Miss Highlights Challenges for Clinical-Stage BiotechTrough Earnings Signal - vinanet.vn
Europe Gene Therapy Market Size, Growth & Forecast, 2034 - Market Data Forecast
Frontier tech research, news & data - MLQ.ai
MBIO Q4 2024 Earnings: Significant EPS Miss Amid Pre-Revenue Biotech OperationsCore Business Growth - vinanet.vn
Car T Cell Therapy Market Set to Booming Growth 2026-2033 | Novartis AG, Gilead Sciences, Inc - EIN News
Mustang Bio stock trades lower as cash runway and trial update shape outlook - Ad-hoc-news.de
Mesa Royalty Trust (MTR) Declines 2.2% as Stock Nears Critical Support at $2.95Shakeout Pattern - po-news-eg.net
MSN Money - MSN
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Significant EPS Miss Amidst Ongoing Operational ChallengesAnalyst Drop Coverage - dars.gov.et
Americore Resources Appoints Justin Hanka to Its Board of Directors - Moomoo
MBIO Q4 2024 Earnings: Massive EPS Miss as Losses WidenEarnings Surprise Score - vinanet.vn
AstraZeneca’s Clinical Setback Casts Doubt on Premium Valuation Amid Pipeline ConcernsMargin Expansion Trends - po-news-eg.net
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Deep Losses Overshadow Progress in CAR T PipelineGuidance Update - DonanımHaber
Mustang Bio (MBIO) Q1 2026 earnings summary - Quartr
Mustang Bio (MBIO) Proxy Filing Summary - Quartr
Mustang Bio (MBIO) Registration Filing Summary - Quartr
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Significant EPS Miss Reflects Operational ChallengesAnnual Financial Report - dars.gov.et
TDW Q1 2026 Earnings: Significant EPS Miss Despite Stock GainDebt Analysis Report - dars.gov.et
MBIO Should I Buy - Intellectia AI
MBIO Q4 2024 Earnings: Massive EPS Miss as Clinical-Stage Biotech Reports No RevenueEarnings Revision Report - dars.gov.et
MBIO Q4 2024 Earnings: Significant EPS Miss as Pre-Revenue Biotech Continues DevelopmentFinancial Summary - dars.gov.et
Enterprise value to EBIT forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBITDA forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBIT forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Price to earnings forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to book forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to earnings forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Enterprise value to revenue forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to sales forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to sales forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Mustang Bio Inc Azioni (MBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mustang Bio Inc Azioni (MBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chill Adam J. | Director |
Dec 30 '25 |
Sale |
0.95 |
4 |
4 |
375 |
| Jin David | Director |
Dec 30 '25 |
Buy |
0.96 |
247 |
238 |
286 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):